title: Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes.
abstract: OBJECTIVE
  Long-term endurance sport practice has been increasingly recognized as a risk factor for lone atrial fibrillation (AF). However, data on the outcome of circumferential pulmonary vein ablation (CPVA) in endurance athletes are scarce. The aim of the study was to evaluate the efficacy of CPVA in AF secondary to endurance sport practice.
  
  
  RESULTS
  Patients submitted to CPVA answered a questionnaire about lifetime history of endurance sport practice. Endurance athletes were defined as those who engaged in >3 h per week of high-intensity exercise for at least the 10 years immediately preceding their AF diagnosis. A series of 182 consecutive patients was included (51 +/- 11 years, 65% with paroxysmal AF, 81% men, 42 +/- 6 mm mean left atrial diameter); 107 (59%) patients had lone AF, and 42 of them (23% of the study population) were classified as endurance athletes (lone AF sport group). Freedom from arrhythmia after a single CPVA was similar in the lone AF sport group compared with the remaining patients (P = 0.446). Left atrial size and long-standing AF were the only independent predictors for arrhythmia recurrence after ablation.
  
  
  CONCLUSIONS
  Circumferential pulmonary vein ablation was as effective in AF secondary to endurance sport practice as in other aetiologies of AF.
authors.affiliation: Cardiology Department, Thorax Institute (ICT), Hospital Clínic, Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), University of Barcelona, Villarroel 170, Barcelona 08036, Catalonia, Spain.
authors.forename: Naiara
authors.initials: N
authors.lastname: Calvo
authors.forename: Lluís
authors.initials: L
authors.lastname: Mont
authors.forename: David
authors.initials: D
authors.lastname: Tamborero
authors.forename: Antonio
authors.initials: A
authors.lastname: Berruezo
authors.forename: Graziana
authors.initials: G
authors.lastname: Viola
authors.forename: Eduard
authors.initials: E
authors.lastname: Guasch
authors.forename: Mercè
authors.initials: M
authors.lastname: Nadal
authors.forename: David
authors.initials: D
authors.lastname: Andreu
authors.forename: Barbara
authors.initials: B
authors.lastname: Vidal
authors.forename: Marta
authors.initials: M
authors.lastname: Sitges
authors.forename: Josep
authors.initials: J
authors.lastname: Brugada
mesh_terms: D056352:Athletes; D001281:Atrial Fibrillation / Q000453:epidemiology* / Q000601:surgery*; D017115:Catheter Ablation / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D010807:Physical Endurance; D011667:Pulmonary Veins / Q000601:surgery*; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D055502:Secondary Prevention; D013030:Spain / Q000453:epidemiology